Related by context. All words. (Click for frequent words.) 63 Guidance Document 59 B.1 59 O. Reg 59 Proposed Revisions 58 MVLWB 58 Approvable 58 END FOOTNOTE 58 FINAL REPORT 58 Permit Application 58 Biological Effects 58 Draft SEIS 58 MB Docket 58 Competitive Impact Statement 58 GASB Issues 58 SEDAR www.SEDAR.com 57 Resubmission 57 Investigational Drugs 57 WDEQ 57 Authorisations 57 Arch Dermatol 57 EMBO J. 56 PennyStockBets.com employees 56 Freshwater Wetlands 56 .cagy veteran 56 Amended Notice 56 Arch Neurol 56 Confirmatory Order 56 #.#-# Offeror Representations 56 Pharmacopoeia USP 56 ISSN #-# 56 Consultation Document 56 Revised Guidance 56 Scrap Tire Cleanup 56 Ann Oncol 56 Am J Epidemiol 56 Genetically Engineered Animals 56 Adjudications Staff 56 § #.# [002] 56 Stipulated Order 56 Supplementary Data 55 Preliminary Findings 55 Docket Number 55 Statement FEIS 55 Continuous Disclosure 55 Waste Discharge 55 CSR #-#.# 55 #:#-# [020] 55 #:#-# [014] 55 Establishment Inspection 55 § #:# [001] 55 #.#-# b [001] 55 Offerors Commercial 55 Annual Bibliography 55 CFR #.# [006] 55 Arch Dis Child 55 Radioactive Material 55 Corrective Actions 55 Counterparty Criteria 55 Radioactive Materials 55 BMC Musculoskeletal Disorders 55 Naturally Occurring 55 FOIA Requests 55 Gerdau Ameristeel Announces 55 Dobhai Ventures Inc. 55 Eur Urol 55 Comment Period 55 Suppl. 55 Coalcorp Provides Updated 55 Expedited Review 54 SUPPLEMENTARY INFORMATION 54 Technical Specifications 54 #:#-# [019] 54 NIH Publication 54 explanatory memoranda 54 IEER 54 Hr'g Tr 54 Biomacromolecules 54 Obes Res 54 Statement EIS 54 http:/www.depweb.state.pa.us Keyword 54 Dkt 54 Reprocessed 54 License Application 54 Product Monograph 54 http:/www.ncbi.nlm.nih.gov/pubmed/# 54 Immunomedics Announces 54 Nonpoint Source 54 Ionizing Radiation 54 Submittal 54 EIR EIS 54 GRI G3 54 BEIR VII 54 Mol Psychiatry 54 NOPR 54 J Clin Epidemiol 54 See Restatement Second 54 Dr. Giles Peatfield 54 Resale Registration Statement 54 Toxicological Sciences 54 Remedial Investigation 54 #:#-# Abstract Free [003] 54 Ord. 54 J Immunol 54 NCDENR 54 www.x cal.com 54 CAS #-#-# Market [001] 54 Subsidiary Arrangements 54 Ann Rheum Dis 54 GOV/#/# 54 EEO Public 54 J Pediatr 54 #-# Full Text 54 NanoMarkets Releases 54 Subpart E 54 CFR #.# [005] 54 WAC #-#-# 54 Interpretative Communication 54 inspectional observations 54 Pub. 54 J Clin Endocrinol Metab 54 Draft Programmatic Environmental Impact 54 Obstet Gynecol 54 Presentence 54 Docket Entry No. 53 Continuous Disclosure Policy 53 GHG Tailoring Rule 53 Nuclear Posture 53 Confirmatory 53 Schibsted ASA SCH 53 Molten Salt 53 DOI #.#/nature# 53 Follow @ JohnCFierce 53 Regulatory Developments 53 MVUM 53 Audited Financials 53 Waiver Request 53 CFR #.# [008] 53 J Natl Cancer Inst 53 Explanatory Note 53 FAR #.#-# Offeror Representations 53 Isotopic 53 Rev. Proc 53 Lou Sessinger column 53 Hr'g 53 NI #-# Preliminary Assessment 53 Major Facility Siting 53 www.nrc.gov 53 #:#-# [002] 53 Lindsey Parnaby 53 Prognostic Factors 53 #.#/science.# 53 CFR § #.# [004] 53 Appendix B 53 Eur J Cancer 53 Certifications Commercial Items 53 DOI #.#/science.# 53 Total Coliform Rule 53 Study Shows Benefits 53 Shared Responsibilities 53 Temporary Suspension 53 #:#-# [010] 53 Permanent Prostate Brachytherapy 53 Electronic Submission 53 FERC Stats 53 Draft EIS 53 B.5 53 #/#/EEC [002] 53 Supplemental Generic 53 Undisputed Facts 53 Occupational Exposure 53 Programmatic Environmental Impact Statement 53 Mineral Extraction 53 Frequently Asked Questions FAQs 53 FNPRM 53 Notice #-# [002] 53 First BanCorp Announces 53 Recommends Approval 53 Environ Health Perspect 53 Amending Directive 53 Vt. Yankee 53 Alfa Laval AB publ 53 See id 53 Ultrasound Guided 53 Bulletin des Annonces 53 Filing Requirements 53 Geochimica et Cosmochimica Acta 53 Erik Ostensoe P. Geo 53 RoHS Compliance 53 CFR #.# [002] 53 Reference Materials 53 Greenhouse Gas Reporting 53 Non Infringement 53 Categorical Exclusion 53 Preliminary Determination 53 § #.#.# [002] 53 Supplementary Prospectus 53 Sources Sought 53 #.#-# [005] 53 proposed rulemaking NPRM 53 Diabet Med 53 AP# reactor design 53 6 pgs #k 53 SHIRE PLC 53 Moderately Priced 53 AirIQ Announces 53 Alexco Announces 53 DFAR #.#-# 53 Doc. No. 52 Salix Pharmaceuticals Announces 52 Offeror Representations 52 Nat Med 52 Appendix 4E 52 Thromb Haemost 52 Chemical Substances 52 Subtitle D 52 Nature doi #.#/nature# 52 Advanced Functional Materials 52 Joint Stipulation 52 MRNF 52 SteroidStocks.com 52 MVEIRB 52 www.nejm.org 52 Final EIS 52 David Gower P.Geo 52 PSE Graded Certificate 52 #:#-# [029] 52 Mitigated Negative Declaration 52 MDDEP 52 AQUARIUS PLATINUM LIMITED 52 Disclosure Controls 52 See CLINICAL PHARMACOLOGY 52 Crit Rev 52 Article ISI ChemPort 52 Pa.RAP 52 Morphine Sulfate 52 Def. s 52 Avcorp announces 52 Photovoltaic Module 52 CFR § #.# [003] 52 Generic Environmental Impact 52 Pl. s 52 doi doi 52 Hospital Outpatient Prospective 52 Follow @ FierceBiotech 52 George Apostolakis 52 Recommends Changes 52 See ARS § 52 N1 #-# 52 SmPC 52 Br J Haematol 52 Submittals 52 Topics Covered Executive 52 J Exp Med 52 #:#-# [027] 52 Position Statement 52 Human Mutation 52 NYSE Amex Listing 52 General Psychiatry #:#-#,# 52 #:#-# [025] 52 Am J Pathol 52 FAR Clause #.#-# 52 B.2 52 #.#-# b [002] 52 SJ Res 52 KEMET Announces 52 DOT OST 52 Submission Guidelines 52 FASEB J. 52 Calgon Carbon Announces 52 What Constitutes 52 CHMP Opinion 52 Toxicol 52 hereby GRANTED 52 article #.#/NEJMoa# 52 Recent Accounting Pronouncements 52 By RohitSharma TennisEarth.com 52 www.thelancet.com 52 document.getElementById root root 52 Lorus Therapeutics Announces 52 Motorized Travel 52 Dr. Arjun Makhijani 52 By KushalSharma TennisEarth.com 52 By GokulPillai TennisEarth.com 52 Evid 52 Am J Cardiol 52 UIC Permit 52 CFR § #.# [001] 52 FFDCA 52 Download PDF 52 Hazardous Drugs 52 Reevaluation 52 Occupational Pension Schemes 52 DOI #.#/hep.# 52 PDEIS 52 Corwin Cor Coe 52 Guest Editorials 52 CDCA Plan 52 SEDAR www.sedar.com www.sedar.com 52 Spent Fuel 52 Specification PAS 52 Rehearing En Banc 52 Pharmacol 52 Carotid Artery Stenting 52 -Sadiola Mine 52 Palaeogeography Palaeoclimatology Palaeoecology 52 Substantial Completion 52 Physical Exams 52 PTET 52 Statement SEIS 51 Kidney Int 51 SEDAR Filings 51 Fund website www.sunamericafunds.com 51 Reply Brief 51 By PAUL QUINLAN 51 Bioterrorism Response 51 Filing Status 51 EuroIntervention 51 Medicure Announces 51 EIS OEIS 51 Eligibility Requirements 51 Brief Description 51 Proposed Arrangement 51 Nuke Waste 51 pp. #-# [004] 51 Ethical Considerations 51 BIOLASE Announces 51 NEJM.org 51 #/#/EC [001] 51 Patent Reexamination 51 Dividend Distribution 51 www.systemc.org 51 Commission website www.comcom.govt.nz 51 EFFECTIVE DATE 51 Detainee Interrogation 51 ANALYST E MAIL 51 Predictive Toxicology 51 Decision #/#/EC 51 CFR § #.# [006] 51 Practice Guideline 51 Cochrane Database Syst Rev 51 IBERIABANK Corporation Reports 51 TCA § #-#-# [003] 51 Am J Clin 51 § #.# b 51 Woody Biomass 51 FR #-# [002] 51 http:/www.usdoj.gov/enrd/Consent Decrees.html 51 Leaves Unanswered Questions 51 ANPRM 51 Ohio Adm.Code #-#-# 51 Complimentary copies 51 #:#-# [018] 51 Flue Gas 51 Arch Gen Psychiatry 51 Plaintiffs Complaint 51 PremierWest Bancorp Announces 51 Renal Function 51 Sahavaara 51 Nat Genet 51 Infect Dis 51 CFR § #.# [008] 51 Recommended Practices 51 Arch Pediatr Adolesc Med 51 Roxanna Maron Summerland 51 #.#-# [033] 51 AvalonBay Communities Announces 51 Rev. Rul 51 Docket ID 51 Coronary Revascularization 51 Reconstitute 51 CEQA Guidelines 51 punctuation omitted 51 Work SOW 51 Flexpoint Announces 51 XPEL Announces 51 Surface Temperature 51 Certifications Commercial 51 Genetically Engineered Crops 51 GRAS Status 51 Qiu Jun Qiujun@xinhua.org 51 visit http:/www.depweb.state.pa.us keyword 51 MANAGEMENT DISCUSSION AND ANALYSIS 51 Classified Documents 51 EIN Presswire Press 51 BALO 51 Cell Biol 51 Clinical Practice Guideline 51 Analytical Methods 51 SteroidStocks.com employees 51 Mineral Resource Estimation 51 Biotechnol 51 #:#-# Abstract Free [009] 51 Regulatory Filing 51 Thermal Conductivity 51 #:#-# Abstract Free [008] 51 doi #.#/pnas.# 51 J Rheumatol 51 Reply Br 51 EIA Notification 51 Crowflight Announces 51 Reinspection 51 Nutrient Requirements 51 @ Gowlings 51 TOFUTTI Announces 51 Supplemental Generic Environmental Impact 51 #:#-# [006] 51 ADAAG 51 Gynecol Oncol 51 Combating Counterfeit Drugs 51 LDEQ 51 adjudicatory proceeding 51 Adverse Event 51 Biological Opinion 51 Silenor NDA 51 #-# www.pardeehospital.org 51 JBJS 51 Tailoring Rule 51 CECPN 51 2L inc 51 Pluripotent Stem Cells 51 Noon Classifieds & 51 Emerg Med 51 Supplemental Environmental Impact 51 Clinical Psychology Review 51 Brain Stimulation 51 #.#B [003] 51 Biogeosciences 51 Issues Clarification 51 GLOBOCAN 51 Burden Reduction 51 SIGNIFICANT ACCOUNTING POLICIES 51 rating nonsignificant 51 § #-#-# [005] 51 FAR #.# 51 FANR 51 Draft Scoping 51 By KarenWalker TennisEarth.com 51 Cooperating Agencies 51 PHD Orders 51 Vapor Intrusion 51 Becomes Effective 51 Product Characteristics 51 FAR #.#-# [003] 51 Publicly Available 51 Advocat Announces 51 NMC Resource 51 reh'g 51 USDA FSIS 51 DOI #.# 51 Clinical Trial Data 51 Exh 51 Substantial Shareholding 51 Langes + 51 Air Worthiness 51 CD# [004] 51 www.nrcan.gc.ca media 51 Going Concern Qualification 51 See USSG 51 CLS interprets 51 #:#-# Abstract Free [002] 51 Proposing Release 51 Antidumping Duties 51 NPT Safeguards Agreement 51 Neurol 51 HNRC 51 3rd edn 51 Randomized Controlled Trials 51 Rate Adjustment 51 Highly Qualified Teacher 51 Material Facts 51 ASX Announcements 51 ROCA Reports 51 Environmental Impacts 51 www.fraserinstitute.ca 51 EPA Proposes 51 Kaydon Corporation Announces 51 Vehicle Warranty 51 Statutory Accounts 51 Microbiol 51 #-#-# [072] 51 Pesticide Programs OPP 51 NSPIRES 51 Diet Supplement 51 Emission Reductions 51 #:#-# Abstract Free [004] 51 Issues Relating 50 Proposed Changes 50 Concluding Observations 50 Radioisotope 50 Biochemical Pharmacology 50 www.ferc.gov 50 :9 50 #:#-# Abstract Free [005] 50 Toxicity Testing 50 ATEX Directive 50 doi #.# 50 Publishes Updated 50 Determination Letter 50 FMIA 50 Substantiation 50 CIGS Photovoltaics 50 Saprolite mafic intrusive 50 REUTERS Toru Hanai 50 Drinking Water Treatment 50 CO2 Sequestration 50 #.#.#R 50 Clin Trials 50 Prequalification 50 Solar Geophysical Activity 50 Segregated Facilities 50 Reclamation Permit 50 Accelerated Approval 50 Crit Care Med 50 Publ 50 Schematic Design 50 Dkt. # 50 Theriogenology 50 LSGP 50 Solicitation Number 50 Dkt. No. 50 CFR § #.# [002] 50 B.3 50 Environment Impact Statement 50 SEC Rule #g# 50 #:# -# [002] 50 Reclassifies 50 NexMed Receives 50 Docket # 50 Lin Fanjing linfanjing@xinhua.org 50 #:#-# Abstract Free [006] 50 By AjayTyagi TennisEarth.com 50 Combined License Application 50 Similac Formula 50 § #-#-# [002] 50 Theratechnologies Announces 50 J Clin Invest 50 FR #-# [001] 50 Peter Dimmell P.Geo 50 CEII 50 SCENIHR 50 nonfinal 50 Amerigo Announces 50 Finsat GCE 50 § #-# [004] 50 Earthstone Energy 50 Regulatory Impact Statement 50 Compl 50 Semiannual Report 50 Resp't 50 #:#-# [001] 50 REUTERS Gary Hershorn 50 Content Outline 50 Policies Procedures 50 #:#-# [032] 50 Mammalian Cell Culture 50 Announces Mailing 50 http:/www.investrend.com/articles/secondlevel.aspHelena Zhu 50 #G# [002] 50 website www.loews.com 50 Tainted Eggs 50 Restricts Access 50 Space Shuttle Processing 50 Mark Baknes P. Geo 50 doi Abstract Free 50 NESHAP 50 Item 9A 50 Listing Application 50 Inspectional Observations 50 Subtitle B 50 Crit Care 50 IDEXX Laboratories Announces 50 Genome Res 50 Contained Contained 50 Habersham Bancorp Announces 50 Nonpublic Postsecondary Educational Institutions 50 FR Doc 50 NJSA #:#-# [004] 50 www.osc.gov.on.ca. 50 Situ Recovery 50 NASDAQ Delisting 50 Interconnection Regulation 50 #.#.#.# [011] 50 REACH SVHC 50 Subdivision Regulations 50 Mr. Amireault 50 Premerger Notification 50 DFARS #.#-# 50 requires Abobe Reader 50 Synalloy Corporation Announces 50 Supplementary Material 50 See IRS Publication 50 CFR #.# [001] 50 GEIS 50 Shoreland Zoning 50 www.aetna.com/#annualreport 50 Act Pub. L. 50 Energy Efficiency Improvements 50 #:#-# [023] 50 #.#-# [016] 50 SEE ATTACHED 50 Article PubMed 50 Systematic Biology 50 www.ncoa.org 50 Proxy Proposals 50 Bundesanstalt für Finanzdienstleistungsaufsicht 50 Rashmi r Parida 50 Implementing Regulations 50 @ nrc.gov 50 Reliability Standards 50 AS NZS #:# 50 #:#-# [033] 50 Deposit Guarantee Schemes 50 SEIR 50 Langley Gulch 50 #/#/EC [003] 50 Final Appraisal Determination 50 J Infect Dis 50 Solicitation Statement 50 Paleobiology 50 Pricing Supplement 50 Ptf 50 High Temperature Superconductivity 50 Ephedra Ban 50 doi #.#/j.#-#.#.#.x 50 EIS EIR 50 Antitumor 50 Subtitle C 50 Ex Parte Reexamination 50 J Pathol 50 Drug Applications sNDAs 50 Notice #-# [001] 50 FAR #.#-# Instructions 50 Corrective Action Plan 50 Equine Veterinary Journal 50 Reasonable Accommodation 50 Res.# 50 Desorption 50 Medoro Resources Announces 50 A.2 50 Regulatory Regime 50 By 3lilangels Read 50 Scoping Document 50 Testosterone Patch 50 ESA Hubble 50 FDA Warns Against 50 www.mayoclinicproceedings.com 50 MDUFMA 50 Pervious Concrete 50 Fuel Enrichment 50 Shelf Prospectus 50 IV.#.# 50 Schweitzer Mauduit Announces 50 Intent NOI 50 Hematological Cancers 50 Retread Press 50 Simplified Prospectus 50 License Renewal 50 #:#-# Abstract Free [010] 50 REUTERS Mick Tsikas 50 doi #.#/S#-# 50 quoting Restatement Second 50 REUTERS Valentin Flauraud 50 ANSI NSF 50 Ann Surg 50 SEIS 50 Docketing 50 Spoliation 50 USSG § #B#.# [002] 50 Nitrogen Oxides NOx 50 Fampridine SR NDA 50 OSV Newbuild Program 50 Individual Retirement Arrangements 50 Erratum 50 SR NYSEArca 50 J Clin Oncol 50 Reference Document 50 Risk Warning 50 Nucleic Acids Res 50 Obligatoires 50 Stmt 50 Article PubMed ISI 50 FAR #.#-# [001] 50 Provider Reimbursement 50 science journal Naturwissenschaften 50 Offerors Commercial Items 50 NJAC 6A 50 #:#-# Abstract Free [001] 50 Exposure Draft 50 dkt item 50 SR ISE 50 Draft EIR 50 Dry Powder Inhalers 50 www.sedar.ca 50 Annuity Transactions Model 50 CFR pt 50 Preliminary Assessment Report 50 CPEX filings 50 Citizen Petition 50 DATES Written comments 50 Directive #/#/EU 50 Income Tax Regs 50 NMR Spectroscopy 49 footnotes omitted 49 § § #-# [001] 49 Am J Gastroenterol 49 Photo EFE 49 De Minimis 49 Endangerment Finding 49 CFR #.# d 49 Study Analyzes 49 By Sylvie Goulet 49 -leukemias 49 Hematopoietic Stem Cells 49 People v. Waidla 49 Integer Overflow Vulnerability 49 draft Supplemental Generic 49 Proposed Regulations 49 Refiling 49 #:#-#,# Medline 49 Electricity Purchase Agreement 49 Resource Calculation 49 news.htm 49 #/#/EC [002] 49 Hazardous Waste Regulations 49 InnoCielo Publisher 49 Remote SQL Query 49 Third Amended Complaint 49 Files Amended 49 FIND THIS STUDY 49 Shelf Registration 49 Free Full Text 49 Wiley Interscience 49 v. Riverkeeper 49 INDUSTRY DEFINITION Industry 49 David Finnis Summerland 49 Lockout Tagout 49 #:# -# [004] 49 No.#/# [001] 49 Advanced Functional 49 Files Voluntary 49 Endocrine Disruptors 49 Declaratory Order 49 Trans Lux Reports 49 Optimised Feasibility Study 49 Novel Foods 49 Exposure Drafts 49 Recommendation Statement 49 Proxy Disclosure 49 Wellhead Protection 49 Reveals Significant 49 Shareholder Proposals 49 MNDM 49 Dkt. 49 Ref. 49 Circular dated 49 Fundamentally Flawed 49 BioFuel Announces 49 #a #a [003] 49 Dietary Reference Intakes 49 DOI #.#/S#-# 49 FEIS 49 Add.1 49 Legal #.# 49 document A/#/#/Add.# 49 Satellite Transponders 49 p.# [001] 49 Largo website www.largoresources.com 49 Endocrine Practice 49 REUTERS Stefan Wermuth 49 Grandfathered Plans 49 www.heritage.org 49 Thallion Announces 49 Reports CTRs 49 RoHS directive #/#/EC 49 Discharge Permit 49 Deo Ferrer Democrat 49 http:/arxiv.org/abs/#.# 49 Tenn. R. Civ 49 www.crystalriverreit.com 49 spokesman Jan Strasma 49 Arch Surg 49 CRZ Notification 49 Springer Verlag Berlin 49 Proposed Rule Making NPRM 49 Assessment DEIA 49 Brownfield Cleanup 49 Fetal Pain 49 Article PubMed ISI ChemPort 49 Diagnostic Radiopharmaceuticals 49 Revised manuscript 49 XM Sirius Merger 49 QAQC protocol 49 www.dol.gov ebsa 49 WA7BNM contest websites 49 Urol 49 Anworth Announces 49 Dangerous Substances 49 R.# [002] 49 attached herewith 49 Radiation Induced 49 Mol Med 49 Eugene Puritch P.Eng 49 Wende supra 49 Asthma Inhalers 49 Differentially 49 Freeze Drying 49 DOI #.#/j.#-#.#.#.x 49 Data Suggest 49 Supplemental Draft Environmental Impact 49 NPDES Permit 49 doi #.#/nature# 49 Headwaters Incorporated Announces 49 OSMRE 49 Emphasizes Need 49 § #-#.# [003] 49 CFR #.#b 49 Priestly Formation 49 CPCN 49 #S #S [002] 49 Hearings Scheduled 49 Clears Path 49 SABESP Announces 49 Credential Evaluation 49 Teva Provides Update 49 § #:# [002] 49 COSHH 49 e# e# [003] 49 http:/www.standardandpoors.com/ 49 La.Civ.Code art 49 Adversary Complaint 49 Antidepressant Treatment 49 www.fda.gov MedWatch 49 Revised Guidelines 49 Hotly Debated 49 #:#-#,# [003] 49 Broadcast Decency 49 Food Labelling 49 Dissertations 49 Evaluation Tool 49 Projected Release Date 49 reh'g denied 49 Envtl 49 Mortgagee Letter #-# 49 Environmental Permitting 49 Proposed Rule Changes 49 Pet'r 49 SEDAR.com 49 Measurement Specialties Announces 49 § #-#.# [001] 49 Surgical Endoscopy 49 Appendices 49 CFR #.# c 49 By BHSN.com Staff 49 HJRes 49 Connie Chng 49 #:#-# [028] 49 J Hypertens 49 Analyte 49 FCC Rcd 49 Noncritical 49 www.covantaholding.com 49 USC #a [001] 49 L# L# [002] 49 Reporting Requirements 49 Structured Finance Transactions 49 doc. 49 ASME Boiler 49 Brent Wahlquist 49 Docosahexaenoic Acid 49 Director Shareholding 49 PPD Declares 49 .W. McNichols 49 Pharmacother 49 Tex. Gov't Code 49 website http:/www.npsp.com 49 EITF Topic D 49 Contents Introduction 49 Quarterly Dividends 49 Appraised Value 49 AHFS DI 49 REUTERS Issei Kato 49 Patentability 49 USC § #u 49 amended Solicitation Recommendation 49 Clinical Guideline 49 TCA § #-#-# [001] 49 #-# compliant Technical 49 Toxics Rule 49 Same Sex Relationships 49 FOIA Request 49 § #B#.# [002] 49 #:#-# [040] 49 http:/hugin.info/#/R/#/#.pdf [001] 49 CorVel Announces 49 Sodium Intake 49 Multiscale Modeling 49 Regulatory Submissions 49 App'x 49 Oxalic Acid 49 Aust Psychiatry 49 EIS Environmental Impact 49 www.ec.gc.ca 49 Inland Wetland 49 MAVDT 49 Statutory Audit 49 Assigns LS 49 Vernon Supp 49 Novel Inhibitor 49 Directors Circular dated 49 Panel Mulls 49 Listing Rule #.#A 49 www.semafo.com 49 Joint Proxy 49 REUTERS Claudia Daut 49 Rehabil 49 diisocyanate 49 Stockholder Proposal 49 Permanent Impairment 49 Acta Psychiatrica Scandinavica 49 Screening Mammography 49 Microfiche 49 Levels Linked 49 Analytical Method 49 Kieran Downes P.Geo 49 BNA Books 49 Effort Fails 49 http:/www.osha.gov 49 Classification Tonnes 49 LSA CCP art 49 Xenonics Announces 49 Whistleblower Protection 49 Psychiatr Serv 49 Notified Bodies 49 :# [002] 49 Carbon Nanotube Based 49 Steam Generator 49 Datasheet 49 LGPO 49 Ozone Pollution 49 Calcium Vitamin D 49 Statistical Methods 49 #.#-# Instructions 49 Pesticide Residues 49 draft SEIS 49 SDEIS 49 LSA RS #:# [001] 49 Polonica 49 Consultation Conclusions 49 Gene Variation 49 Docosahexaenoic Acid DHA 49 Clin Infect Dis 49 J Nutr 49 Biol Psychiatry 49 Injectable Drug 49 Complaint ¶ 49 Assumed Name 49 Slip op 49 Printed Materials 49 FCC Rcd # 49 Greenhouse Gas Emission 49 www.eco system.com 49 NRC 49 Acne Drug 49 Wastewater Discharge 49 website www.inter citic.com 49 Lowering Blood Pressure 49 La.Code Crim.P. art 49 Wastewater Facilities 49 Implementation Guides 49 Lawsuit Involving 48 REUTERS Arnd Wiegmann 48 Avantage Financial GmbH 48 ots.CorporateNews transmitted 48 www.rda.com 48 Western Airborne Contaminants 48 #:#-#,# [002] 48 Clinical Infectious Disease 48 # Hydroxycut 48 NASDAQ Deficiency Notice 48 Groundwater Monitoring 48 Colo. Sess 48 Decision ROD 48 WC Docket No. 48 Calgary AB T2P 48 Int J Epidemiol 48 #:#-# [038] 48 Milbank Quarterly 48 Electromagnetic Fields 48 Cashflow Report 48 Raw #/#/# Punjab 48 Evaluation Process 48 Air Pollutants 48 Offerors shall 48 Geier supra 48 internal quotations omitted 48 #.#.#.#.#.# 48 ChemPort 48 Spent Nuclear 48 REUTERS David Mdzinarishvili